Navigation Links
Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS/FFR Systems

SAN DIEGO and ERLANGEN, GERMANY, Aug. 25 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis of coronary and peripheral artery disease, announced today that it has entered into a non-exclusive, global resale agreement with Siemens Healthcare, a sector of Siemens AG (NYSE: SI). Under this agreement, Siemens will resell Volcano-branded s5i IVUS/FFR systems and accessories alongside Siemens' Artis family of X-ray systems.

The Volcano s5i intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system is compatible with Artis X-ray offerings. Volcano's s5i is a component-based system that is incorporated directly into the cath lab, allowing IVUS and FFR to be always on and always ready.

As a technology leader in the cath lab market, Siemens strives to offer the most complete, state-of- the-art cath lab -- while focusing on optimal work-flows. Volcano's s5i IVUS system is uniquely suited to meet those needs, as it interacts seamlessly with the Siemens x-ray systems.

Physicians are recognizing the value of IVUS and FFR as an integral part of daily percutaneous coronary interventions. Volcano's IVUS technology gives clinicians the ability to visualize vessel geometry, understand plaque composition and make measurements for stent sizing. Volcano's FFR technology allows physicians to make a physiological measurement of a lesion to assess the requirement for treatment. Volcano's s5i system uniquely integrates both technologies into the cath lab on one system.

"IVUS and FFR usage is growing worldwide, and more and more hospitals are seeking to include these technologies in their cath lab design from the very beginning," commented Scott Huennekens, president and chief executive officer of Volcano. "Our agreement with Siemens Healthcare is yet another example of Volcano's commitment to provide clinicians with market leading IVUS and FFR technology that functions seamlessly with their X-ray equipment."

"With our Artis system, we bring the best in state-of-the-art cath lab technology to the market." said Dr. Georg Nollert, Global Marketing Manager Cardiology Systems. "Offering Volcano's s5i IVUS / FFR system integrated into the Artis system supports our goal of bringing best-in-class solutions to the interventional cardiologist."

The Volcano - Siemens resale agreement builds upon the established compatibility between the Siemens Artis system and the Volcano s5i integrated IVUS system previously demonstrated at the American College of Cardiology (ACC) meetings.

About Volcano Corporation

Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward-Looking IVUS systems and catheters. Currently, more than 4,400 Volcano IVUS and FM systems are installed worldwide, and more than half of Volcano's revenues are derived from outside the United States. Through its wholly-owned subsidiary, Axsun Technologies, Volcano also develops and manufactures optical monitors, lasers and optical engines used in telecommunications, spectroscopy and other industrial applications. These products are sold to a variety of customers, including Nokia Siemens, Ericsson, Alcatel-Lucent and HuaWei Technologies. For more information, visit the company's website at

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit:

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release regarding Volcano's business that are not historical facts may be considered "forward-looking statements," including statements regarding the company's financial guidance for 2009, market adoption of the company's technology, the impact of clinical and other technical data, the timing and impact of the company's transition to a direct sales force in Japan, including impact on revenue, expenses and income, growth strategies, market development and product sales. Forward-looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties, which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from the results predicted are detailed in the company's annul report on Form 10-K, quarterly reports on Form 10-Q and other filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.

SOURCE Volcano Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman
2. Volcano Announces OCT Activities at EuroPCR 2009
3. Volcano Corporation Presentation at JMP Conference to be Webcast
4. Volcano Corporation Presentation at Bank of America/Merrill Lynch Conference to be Webcast
5. Volcano Corporation Announces Webcast of February 25th Analyst Day
6. Volcano Reports Full Year Revenues Increase 31 Percent
7. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
8. Volcano Highlights Commitment, Market Acceptance of FFR Product Line
9. Reminder: Volcano Corporation Schedules Conference Call, Webcast to Discuss Axsun Transaction
10. Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast
11. Volcano Reports 40 Percent Growth in Quarterly Revenues
Post Your Comments:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... a safe and convenient way to dispense prescription medications at home, so he ... effective way to monitor and dispense prescription medications. In doing so, it could ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... an innovative online platform for mental health and wellness consultation, has collaborated with ... partnership will bridge the knowledge gap experienced by parents and bring advice from ...
(Date:11/27/2015)... ... 27, 2015 , ... Indosoft Inc., developer and distributor of ... 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making ... with a version of Asterisk that will receive not only security fixes, but ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 ... the potential to use SyMRI to find optimal contrast weighting ... brain tumor metastases, and has signed a research agreement with ... at the hospital. Using SyMRI, it is possible to generate ... parameter settings after the patient has left, thus making it ...
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the French ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 Research ... of the "Advanced Wound Care Market by Type ... Ulcers), End User (In-Patient Facility, Out-Patient Facility), and Geography ... offering. --> --> ... the description, definition and forecast of the global advanced ...
Breaking Medicine Technology: